Xylem Inc.

NYSE:XYL Stock Report

Market Cap: US$35.0b

Xylem Balance Sheet Health

Financial Health criteria checks 6/6

Xylem has a total shareholder equity of $11.3B and total debt of $2.0B, which brings its debt-to-equity ratio to 17.6%. Its total assets and total liabilities are $17.2B and $5.9B respectively. Xylem's EBIT is $1.2B making its interest coverage ratio 151.1. It has cash and short-term investments of $1.2B.

Key information

17.65%

Debt to equity ratio

US$2.00b

Debt

Interest coverage ratio151.1x
CashUS$1.17b
EquityUS$11.31b
Total liabilitiesUS$5.88b
Total assetsUS$17.19b

Recent financial health updates

Recent updates

Xylem: Growth Fully Justifies The High Multiple

Aug 19

Is Xylem Inc. (NYSE:XYL) Potentially Undervalued?

Aug 01
Is Xylem Inc. (NYSE:XYL) Potentially Undervalued?

Xylem (NYSE:XYL) Seems To Use Debt Rather Sparingly

Jul 16
Xylem (NYSE:XYL) Seems To Use Debt Rather Sparingly

Is Xylem Inc. (NYSE:XYL) Trading At A 21% Discount?

Jun 25
Is Xylem Inc. (NYSE:XYL) Trading At A 21% Discount?

Xylem: An Undervalued Stock With Secular Tailwinds

Apr 29

Xylem Inc.: Bubbling For Long-Term Growth

Mar 28

Getting In Cheap On Xylem Inc. (NYSE:XYL) Might Be Difficult

Jan 27
Getting In Cheap On Xylem Inc. (NYSE:XYL) Might Be Difficult

Xylem: A Strong Water Play Starts To Look More Compelling

Jan 14

Is Now An Opportune Moment To Examine Xylem Inc. (NYSE:XYL)?

Dec 16
Is Now An Opportune Moment To Examine Xylem Inc. (NYSE:XYL)?

Xylem (NYSE:XYL) Seems To Use Debt Rather Sparingly

Dec 02
Xylem (NYSE:XYL) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Xylem Inc. (NYSE:XYL) Suggests It's 25% Undervalued

Nov 19
An Intrinsic Calculation For Xylem Inc. (NYSE:XYL) Suggests It's 25% Undervalued

Xylem: Healthy Dividend Growth With Strong Long-Term Tailwinds

Nov 04

Xylem Inc. (NYSE:XYL) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 03
Xylem Inc. (NYSE:XYL) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Investors Still Waiting For A Pull Back In Xylem Inc. (NYSE:XYL)

Oct 23
Investors Still Waiting For A Pull Back In Xylem Inc. (NYSE:XYL)

Xylem: Good Performance Likely To Be Fully Priced In

Sep 07

At US$136, Is It Time To Put Xylem Inc. (NYSE:XYL) On Your Watch List?

Aug 30
At US$136, Is It Time To Put Xylem Inc. (NYSE:XYL) On Your Watch List?
User avatar

Evoqua Acquisition And MCS Expansion Propel Earnings And Revenue Surge

Xylem's strong market demand and the successful integration of Evoqua are improving revenue growth and net margins through operational efficiencies.

Xylem: Wait For Multiple Contraction For This Excellent Company

Jun 21

Xylem: Bigger Does Not Mean Better Shareholder Value

Apr 04

Xylem: Fund Managers Like This Top ESG-Rated Stock

Jan 22

Xylem: Good Prospects, But Pricey

Nov 09

Xylem: Overvalued Stock Despite An Interesting Merger

Oct 24

Financial Position Analysis

Short Term Liabilities: XYL's short term assets ($4.4B) exceed its short term liabilities ($2.3B).

Long Term Liabilities: XYL's short term assets ($4.4B) exceed its long term liabilities ($3.6B).


Debt to Equity History and Analysis

Debt Level: XYL's net debt to equity ratio (7.3%) is considered satisfactory.

Reducing Debt: XYL's debt to equity ratio has reduced from 113.2% to 17.6% over the past 5 years.

Debt Coverage: XYL's debt is well covered by operating cash flow (61.3%).

Interest Coverage: XYL's interest payments on its debt are well covered by EBIT (151.1x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/25 16:30
End of Day Share Price 2025/08/22 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xylem Inc. is covered by 42 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Richard RadbourneAtlantic Equities LLP
Michael HalloranBaird